scorecardresearch
Add as a preferred source on Google
Friday, January 9, 2026
TopicICMR

Topic: ICMR

Flagging bird flu’s ‘pandemic potential’, ICMR calls on private firms to collaborate on human vaccine

India's apex health research body has warned that H5N1 infection in humans has a high case fatality rate, exceeding 50 percent.

How cancer daycare centres promised in Budget 2025 aim to ease treatment costs, access

Cancer care in India is marked by barriers of access & disparities in availability of quality care. Daycare centres at district hospitals could save patients up to Rs 10,000 cr annually.

Why a govt-appointed panel has recommended a complete ban on popular painkiller nimesulide

First launched in Italy in 1985, Nimesulide is available in India under brand names like Nimuwin, Nimutab, Nimopen, Nisulid, Nimdase, Nodard Plus, Nicip, Nimcap, Nicip-P and Nimupain.

Bengaluru HMPV cases are infants who didn’t go abroad. Govt says no unusual surge in respiratory illness

Of the two infant patients, one has been discharged, while the other is recovering. Experts & Centre stress Human Metapneumovirus not new & has been circulating for many years.

ICMR proposes testing of TB at village level in revised national essential diagnostics list

Maximum increase is at the level of district hospitals from 117 to 171 tests, according to draft NEDL 2025. ASHAs to carry out 9 tests instead of 6 if proposal gets nod.

Life-threatening bloodstream infections 54% costlier to treat when caused by superbugs—ICMR study

Study conducted by 13 organisations found that in govt hospitals, direct median total cost for treating bloodstream infections triggered by antimicrobial-resistant bacteria was Rs 89,377.

Killer superbugs mainly emerging from hospitals, not animals & environment—study by Indian, UK scientists

Study by scientists associated with ICMR, Cambridge University and Christian Medical College (CMC), Vellore, was published Tuesday in the Journal of Epidemiology and Global Health.

India had highest number of diabetics in the world in 2022, 62% were not on medication—Lancet report

Study conducted by NCD Risk Factor Collaboration (NCD-RisC) and WHO. Findings part of first global analysis of trends in both diabetes rates and treatment across countries.

Low-sugar diet in 1st 1,000 days of life lowers risk of diabetes, hypertension in adults—Science study

Low sugar intake by mother during pregnancy lowers risks & continued restriction after birth increases benefits, finds study by researchers from California & Montreal universities.

Under 50% pet dogs vaccinated against rabies, 60% bite victims don’t complete vaccine course—ICMR survey

Nationwide survey on animal bite burden & human rabies estimates 5,726 human rabies deaths annually, down 75% in 20 years, suggests steps to eliminate dog-mediated human rabies by 2030.

On Camera

Why Pinarayi Vijayan is going soft on an Ezhava leader’s anti-Muslim hate speech

Pinarayi Vijayan once called Vellappally Natesan, the general secretary of SNDP Yogam, Kerala’s Pravin Togadia. Now he is giving his hate speech a free pass.

500% tariffs ahead for India? Trump’s lined up a big bad Bill for countries buying Russian oil

Republican Senator Lindsey Graham says bill will be 'well-timed, as Ukraine is making concessions for peace and Putin is all talk, continuing to kill the innocent'.

2025: Pakistan’s deadliest year in over a decade

Islamabad-based think-tank PICSS's new report says Pakistan saw 'pronounced escalation' in violence last year, with 3,413 conflict-related deaths compared to 1,950 in previous year.

A year-end Mea Culpa in National Interest—The Army-Islam combo doesn’t kill democracy

Many of you might think I got something so wrong in National Interest pieces written this year. I might disagree! But some deserve a Mea Culpa. I’d deal with the most recent this week.